Get results in 30 minutes.
3 min read
This article has been translated from our English edition.
This story originally appeared on Business Insider
The U.S. Food and Drug Administration (FDA) approved the first COVID-19 home emergency test kit on Tuesday.
The COVID-19 All-In-One Test Kit, manufactured by the biotech company Lucira Health, is the first nasal swab test that can be completely self-administered at home and, according to the government agency, provides results in 30 minutes or less.
After the patient has used the nasal swab, it is shaken into a vial and placed in a test unit. Within minutes, the lights will indicate whether the person is positive, negative, or needs to be retested.
The single-use test has been approved for people over the age of 14 if their healthcare provider suspects they may have coronavirus, according to the FDA. It has only been approved for prescription use.
The kit can also be used in hospitals, emergency centers and emergency rooms. However, patients under the age of 14 must have their sample drawn by a health care provider, according to the FDA.
FDA Commissioner Stephen M. Hahn said in the statement, “While COVID-19 diagnostic tests have been approved for at-home collection, this is the first to be self-administered and give at-home results.
“This new testing option is an important diagnostic advance in tackling the pandemic and reducing the public burden of disease transmission.”
More than 11.4 million people in the US are infected with the coronavirus / Image: Depositphotos.com
The FDA didn’t say how much the test would cost, the Lucira Health website says the test “should cost less than $ 50”.
Business Insider contacted Lucira for a comment.
More than 11.4 million people in the United States are infected with coronavirus and more than 248,000 people have died from it, according to the COVID-19 tracker New York Times.
The United States has more cases than any other country and is currently experiencing a third wave of infections.